Showing results (131-140 of 159) with videos related to
Sort By:
Pageof 16
Cancer|May 25, 2011
An E3 ubiquitin ligase: c-Cbl: a new therapeutic target of lung cancerFang-Yi Lo, Yi-Hung Carol Tan, Hung-Chi Cheng, et al.Annals of the Academy of Medicine, Singapore|February 4, 2010
Stress levels amongst caregivers of patients with osteoporotic hip fractures - a prospective cohort studyMashfi Qul Siddiqui, Lynette Sim, Joyce Koh, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 21, 2010
Role of integrated 18-fluorodeoxyglucose position emission tomography-computed tomography in patients surveillance after multimodality therapy of malignant pleural mesotheliomaCarol Tan, Sally Barrington, Sheila Rankin, et al.American Journal of Respiratory Cell and Molecular Biology|October 7, 2006
Plasmacytoid dendritic cells from human lung cancer draining lymph nodes induce Tc1 responsesAlexander Faith, Emma Peek, Joanne McDonald, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2020
Spatial and Temporal Heterogeneity of PD-L1 Expression and Tumor Mutational Burden in Gastroesophageal Adenocarcinoma at Baseline Diagnosis and after ChemotherapyKatherine I Zhou, Bryan Peterson, Anthony Serritella, et al.International Journal of General Medicine|April 15, 2014
Role of pneumococcal vaccination in prevention of pneumococcal disease among adults in SingaporePhilip Eng, Lean Huat Lim, Chian Min Loo, et al.Cureus|April 20, 2016
The Chicago Thoracic Oncology Database Consortium: A Multisite Database InitiativeBrian Won, George B Carey, Yi-Hung Carol Tan, et al.International Journal of Medical Sciences|June 27, 2013
Lack of association of C-Met-N375S sequence variant with lung cancer susceptibility and prognosisJiunn-Min Shieh, Yen-An Tang, Tsung-Han Yang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2013
Adjuvant MAGE-A3 immunotherapy in resected non-small-cell lung cancer: phase II randomized study resultsJohan Vansteenkiste, Marcin Zielinski, Albert Linder, et al.Cancer|September 21, 2021
Immune-related adverse events are associated with improved response, progression-free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitorsCorey C Foster, Marcus A Couey, Sara E Kochanny, et al.Pageof 16